Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICH and USP Agree to Harmonize Metal Impurity Limits

This article was originally published in The Gold Sheet

Executive Summary

ICH and USP have announced plans to harmonize their limits in pharmaceuticals for elemental impurities like arsenic, lead, cadmium and mercury. An ICH Q3D Step 4 guideline that sets these limits is imminent.

You may also be interested in...



USP Proposes Analytical Methods For Drug Makers To Detect Nitrosamine Impurities

The USP has launched an initiative to address the nitrosamine crisis by proposing a new general chapter that outlines a set of analytical methods that manufacturers can use to demonstrate their products are free from unsafe levels of these potential carcinogens. The chapter is aligned with the FDA’s guidance on nitrosamine impurities.

ICH Urged to Allow for Bioaccessibility in Metal Impurities Standards

The world’s leading drug regulatory authorities aim to agree in a June ICH meeting on final standards for elemental impurities like arsenic, lead, cadmium and mercury. Industry has some ideas on what they should decide.

Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others

Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”

Topics

UsernamePublicRestriction

Register

PS000810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel